SCHEMBL21292827

SCHEMBL21292827

O=C(NN=Cc1cc([N+](=O)[O-])ccc1O)c1ccc(Cl)cc1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PHGDH O43175 2/20 0.76
KDM4E B2RXH2 8/20 0.75
MAPT P10636 6/20 0.75
TDP1 Q9NUW8 4/20 0.75
ALDH1A1 P00352 3/20 0.75
L3MBTL1 Q9Y468 3/20 0.75
MEN1 O00255 7/20 0.68
KMT2A Q03164 7/20 0.68
NPC1 O15118 2/20 0.68
HTT P42858 3/20 0.67
LMNA P02545 2/20 0.67
SMN1; SMN2 Q16637 2/20 0.67
KDM1A O60341 1/20 0.66
POLB P06746 3/20 0.63
BLM P54132 2/20 0.63
RAB9A P51151 2/20 0.63
PSMD14 O00487 1/20 0.63
MMP2 P08253 1/20 0.63
CASP3 P42574 1/20 0.61
SENP8 Q96LD8 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL683820 1.00 PHGDH (0.76) PHGDHKDM4EMAPTTDP1ALDH1A1
SCHEMBL684833 0.93 KDM1A (0.73) PHGDHKDM4EMAPTTDP1ALDH1A1
SCHEMBL21292771 0.93 PHGDH (0.82) PHGDHKDM4EMAPTTDP1ALDH1A1
SCHEMBL21292769 0.93 PHGDH (0.82) PHGDHKDM4EMAPTTDP1ALDH1A1
SCHEMBL21292819 0.90 PHGDH (0.79) PHGDHKDM4EMAPTTDP1ALDH1A1
SCHEMBL16035055 0.90 PHGDH (0.79) PHGDHKDM4EMAPTTDP1ALDH1A1
SCHEMBL8292619 0.89 KDM1A (0.67) PHGDHKDM4EMAPTTDP1ALDH1A1
SCHEMBL21292677 0.89 PHGDH (0.81) PHGDHKDM4EMAPTTDP1ALDH1A1
SCHEMBL21292675 0.89 PHGDH (0.81) PHGDHKDM4EMAPTTDP1ALDH1A1
SCHEMBL21292751 0.88 PHGDH (0.76) PHGDHKDM4EMAPTTDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10722489-B2 D-3-phosphoglycerate dehydrogenase allosteric inhibitor and use thereof PEKING UNIVERSITY (CN) 2020-07-28 US disclosed
US-20200054593-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF UNIV BEIJING (CN) 2020-02-20 US disclosed
US-20190262303-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF UNIV BEIJING (CN) 2019-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10722489-B2 D-3-phosphoglycerate dehydrogenase allosteric inhibitor and use thereof MDH2, MDH1, DLD PHGDH 4/4885KDM4E 1863/4885MAPT 3785/4885
US-20200054593-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF MDH2, MDH1, DLD PHGDH 4/4885KDM4E 1863/4885MAPT 3785/4885
US-20190262303-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF MDH2, MDH1, DLD PHGDH 4/4885KDM4E 1863/4885MAPT 3785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.